Documentation Standards Flashcards

A pharmacist discovers that a prescription adaptation was documented in the patient's profile but the prescriber was not notified within the required timeframe due to a system outage. Under NAPRA's Model Standards of Practice, which of the following best describes the pharmacist's obligation after the fact?

Answer: Document the system outage as the reason, notify the prescriber as soon as reasonably possible, and record the date and method of that delayed notification

NAPRA standards require that when a pharmacist adapts a prescription, they must notify the prescriber in a timely manner and document that notification. If notification was delayed due to circumstances beyond control, the pharmacist must still notify the prescriber as soon as practicable and document the delay, its reason, and the subsequent communication. Voiding the adaptation is not warranted, and mandatory regulatory reporting thresholds are not triggered by a documentation delay alone.

A pharmacy technician initials a narcotic count discrepancy entry in the narcotics register before the pharmacist has verified and countersigned it. Under the Controlled Drugs and Substances Act documentation requirements, what is the correct course of action?

Answer: The pharmacist must investigate the discrepancy, document the findings, and countersign the entry; the technician's premature initialling must also be noted

Under CDSA regulations, narcotics records require pharmacist oversight and countersignature. When a discrepancy exists, the pharmacist bears accountability for investigation and documentation of the resolution. The technician initialling prematurely does not invalidate the entry outright, but the pharmacist must document the investigation findings and countersign. Creating an entirely new entry or voiding the original is not the standard approach — corrections to controlled substance records should be made transparently with annotations, not deletions.

A patient requests a copy of their medication record under provincial privacy legislation. The record contains a pharmacist's clinical note indicating suspected non-adherence linked to possible cognitive decline. Which approach best balances documentation standards with privacy obligations?

Answer: Provide the full record as requested; patients have a right of access to their own health information including clinical notes, though the pharmacist may include a brief explanatory note

Under PIPEDA and provincial health privacy legislation (e.g., PHIPA in Ontario, HIA in Alberta), individuals generally have the right to access their own personal health information, including clinical notes recorded by a pharmacist. The pharmacist cannot routinely withhold clinical impressions simply because they are speculative — however, a narrow exemption may apply if disclosure could cause serious harm. The pharmacist may add context but cannot categorically deny access. Clinical notes are not universally exempt 'internal documents' under Canadian law.

When documenting a MedsCheck in Ontario, a pharmacist completes the required MedsCheck form but forgets to document the follow-up plan in the patient's pharmacy record. The MedsCheck claim has already been submitted to ODB. What is the most appropriate corrective action?

Answer: Add a late entry to the patient's pharmacy record clearly marked with the current date, time, and notation that it is a late entry, documenting the follow-up plan discussed during the original visit

Documentation standards permit late entries provided they are clearly identified as such — including the date and time the entry was made and indicating it is a late addition. The patient's pharmacy record must contain the follow-up plan as part of complete MedsCheck documentation. The MedsCheck form alone does not satisfy the full pharmacy record requirement. Conducting a new visit would be inappropriate and potentially fraudulent if billed again. Resubmitting to ODB is a separate billing matter unrelated to the clinical record obligation.

A pharmacist receives a verbal order from a physician for a hospital inpatient and transcribes it onto a medication administration record (MAR). The physician later reviews the MAR and believes the dose documented differs from what was verbally communicated. Neither party has a contemporaneous written record. Under documentation best practices, how should this discrepancy be resolved?

Answer: Both the pharmacist and physician should document their recollections independently with timestamps, the discrepancy should be escalated to the patient care team and risk management, and the medication should be held pending clarification

When a discrepancy exists between two parties' recollections of a verbal order, no single party's account automatically supersedes the other. Best practice requires independent documentation of each party's recollection with clear timestamps, immediate escalation to appropriate clinical and risk management channels, and withholding the medication pending resolution to protect patient safety. Amending the record unilaterally to favour one party's account without evidence is inappropriate. Destroying original documentation is never acceptable — it may constitute record tampering.

A pharmacist in a long-term care facility discovers that a nurse has been signing the medication administration record (MAR) for administration of a Schedule I controlled substance on behalf of another nurse who was too busy. No actual medication administration error occurred. From a pharmacy documentation standards and regulatory perspective, what is the primary concern?

Answer: Proxy signing of controlled substance MARs constitutes a falsification of an official record, undermines the audit trail required under the CDSA, and must be reported through the facility's incident reporting system regardless of whether a harm occurred

Controlled substance documentation requires that the person who administers the medication signs the MAR — proxy signing constitutes record falsification, even when the drug was genuinely administered. The CDSA and provincial regulations rely on accurate individual accountability records to maintain the integrity of the controlled substance audit trail. A harm-free outcome does not eliminate the documentation violation. Pharmacists have a professional obligation to ensure the integrity of controlled substance records and must escalate through incident reporting channels. This is not exclusively a nursing matter when it implicates the pharmacy's controlled substance oversight.